Insights into the post-translational modification and its emerging role in sha** the tumor microenvironment

W Li, F Li, X Zhang, HK Lin, C Xu - Signal transduction and targeted …, 2021 - nature.com
More and more in-depth studies have revealed that the occurrence and development of
tumors depend on gene mutation and tumor heterogeneity. The most important …

Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs

J Shelton, X Lu, JA Hollenbaugh, JH Cho… - Chemical …, 2016 - ACS Publications
Nucleoside, nucleotide, and base analogs have been in the clinic for decades to treat both
viral pathogens and neoplasms. More than 20% of patients on anticancer chemotherapy …

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif… - autophagy, 2021 - Taylor & Francis
In 2008, we published the first set of guidelines for standardizing research in autophagy.
Since then, this topic has received increasing attention, and many scientists have entered …

CRISPR-mediated tagging of endogenous proteins with a luminescent peptide

MK Schwinn, T Machleidt, K Zimmerman… - ACS chemical …, 2018 - ACS Publications
Intracellular signaling pathways are mediated by changes in protein abundance and post-
translational modifications. A common approach for investigating signaling mechanisms and …

Protein neddylation and its alterations in human cancers for targeted therapy

L Zhou, W Zhang, Y Sun, L Jia - Cellular signalling, 2018 - Elsevier
Neddylation, a post-translational modification that conjugates an ubiquitin-like protein
NEDD8 to substrate proteins, is an important biochemical process that regulates protein …

NRF2 activation in cancer: from DNA to protein

EW Cloer, D Goldfarb, TP Schrank, BE Weissman… - Cancer research, 2019 - AACR
Abstract The Cancer Genome Atlas catalogued alterations in the Kelch-like ECH-associated
protein 1 and nuclear factor erythroid 2–related factor 2 (NRF2) signaling pathway in 6.3% of …

E1 enzymes as therapeutic targets in cancer

SH Barghout, AD Schimmer, E Barker - Pharmacological reviews, 2021 - Elsevier
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …

Cullin-RING Ligases as attractive anti-cancer targets

Y Zhao, Y Sun - Current pharmaceutical design, 2013 - ingentaconnect.com
The ubiquitin-proteasome system (UPS) promotes the timely degradation of short-lived
proteins with key regulatory roles in a vast array of biological processes, such as cell cycle …

Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions

DJ Fu, T Wang - Journal of Hematology & Oncology, 2023 - Springer
NEDDylation, a post-translational modification through three-step enzymatic cascades,
plays crucial roles in the regulation of diverse biological processes. NEDD8-activating …

Targeting lncRNA DDIT4‐AS1 sensitizes triple negative breast cancer to chemotherapy via suppressing of autophagy

T Jiang, J Zhu, S Jiang, Z Chen, P Xu… - Advanced …, 2023 - Wiley Online Library
In this study, it is found that the lncRNA, DNA damage inducible transcript 4 antisense RNA1
(DDIT4‐AS1), is highly expressed in triple‐negative breast cancer (TNBC) cell lines and …